Day: May 4, 2026

us corporate news

Glaukos Corp Leads Innovation in Chronic Eye Disease Treatment with iDose TR and Epioxa Therapies – 2026 Investor Update

Minichart

May 4, 2026

Glaukos Corp 2026 Investor Presentation - Detailed Report ...

Continue Reading 0

us corporate news

Indivior Announces $175 Million Accelerated Share Repurchase Agreement Under Existing Authorization

Minichart

May 4, 2026

Indivior Announces \$175 Million Accelerated Share Repurchas...

Continue Reading 0

us corporate news

CALISA ACQUISITION CORP Files Form 8-K: Company Details, NASDAQ Listings, and Executive Information (April 30, 2026)

Minichart

May 4, 2026

Calisa Acquisition Corp Receives Nasdaq Non-Compliance Notic...

Continue Reading 0

us corporate news

GameStop Proposes $55.5 Billion Acquisition of eBay at $125 Per Share with Major Cost Reductions and Leadership by Ryan Cohen

Minichart

May 4, 2026

GameStop Proposes \$55.5 Billion Acquisition of eBay — Key D...

Continue Reading 0

us corporate news

Spirit Airlines Cancels All Flights and Begins Orderly Wind-Down of Operations Amid Financial Challenges

Minichart

May 4, 2026

Analysis and Potential Share Price Impact This announce...

Continue Reading 0

us corporate news

Apellis Pharmaceuticals, Inc. Files Form 8-K with SEC Detailing Company Information and Executive Provisions

Minichart

May 4, 2026

Apellis Pharmaceuticals, Inc. - 8-K Report Analysis: Key Det...

Continue Reading 0

us corporate news

CNS Pharmaceuticals Announces Private Placement Agreement and Pre-Funded Warrants Offering – Details and Legal Terms

Minichart

May 4, 2026

CNS Pharmaceuticals, Inc. Announces Private Placement and Re...

Continue Reading 0

us corporate news

Cogent Communications Q1 2026 Financial Results: Service Revenue at $239.2M, Wavelength Growth, and Dividend Announcement 1

Minichart

May 4, 2026

Cogent Communications Q1 2026 Earnings - Investor Review ...

Continue Reading 0

us corporate news

ADMA Biologics’ ASCENIV Receives FDA Approval to Treat Pediatric Immunodeficiency Patients Aged 2 and Older

Minichart

May 4, 2026

ADMA Biologics Announces Significant FDA Approval Expanding ...

Continue Reading 0

us corporate news

BioCryst Pharmaceuticals, Inc. Files Form 8-K with SEC – Company Details, Stock, and Contact Information (May 2026)

Minichart

May 4, 2026

BioCryst Pharmaceuticals, Inc. (BCRX) - 8-K Filing Report fo...

Continue Reading 0

Day: May 4, 2026

Join Our Investing Seminar